A detailed history of Boston Partners transactions in Boston Scientific Corp stock. As of the latest transaction made, Boston Partners holds 23,567 shares of BSX stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,567
Previous 23,757 0.8%
Holding current value
$2.13 Million
Previous $1.83 Million 7.93%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$72.96 - $84.0 $13,862 - $15,960
-190 Reduced 0.8%
23,567 $1.97 Million
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $8,416 - $9,713
-125 Reduced 0.52%
23,757 $1.83 Million
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $118,828 - $141,563
-2,063 Reduced 7.95%
23,882 $1.64 Million
Q4 2023

Feb 07, 2024

SELL
$48.64 - $57.81 $591,851 - $703,432
-12,168 Reduced 31.93%
25,945 $1.5 Million
Q2 2023

Aug 10, 2023

BUY
$49.72 - $54.64 $11,286 - $12,403
227 Added 0.6%
38,113 $2.06 Million
Q1 2023

May 09, 2023

SELL
$45.09 - $50.03 $9,288 - $10,306
-206 Reduced 0.54%
37,886 $1.9 Million
Q4 2022

Feb 07, 2023

SELL
$39.56 - $47.22 $771,261 - $920,601
-19,496 Reduced 33.85%
38,092 $1.76 Million
Q3 2022

Nov 09, 2022

BUY
$36.71 - $109.66 $15,491 - $46,276
422 Added 0.74%
57,588 $2.23 Million
Q2 2022

Aug 10, 2022

SELL
$35.24 - $47.1 $85.6 Million - $114 Million
-2,428,483 Reduced 97.7%
57,166 $2.13 Million
Q1 2022

May 10, 2022

BUY
$40.9 - $45.1 $2.06 Million - $2.27 Million
50,301 Added 2.07%
2,485,649 $110 Million
Q4 2021

Feb 04, 2022

SELL
$38.07 - $44.87 $424,861 - $500,749
-11,160 Reduced 0.46%
2,435,348 $103 Million
Q3 2021

Nov 05, 2021

BUY
$41.23 - $45.88 $2.75 Million - $3.07 Million
66,818 Added 2.81%
2,446,508 $106 Million
Q2 2021

Aug 12, 2021

BUY
$38.58 - $44.24 $1.35 Million - $1.54 Million
34,868 Added 1.49%
2,379,690 $102 Million
Q1 2021

May 10, 2021

BUY
$35.27 - $39.67 $8.18 Million - $9.2 Million
232,038 Added 10.98%
2,344,822 $90.7 Million
Q4 2020

Feb 04, 2021

BUY
$33.15 - $41.97 $989,096 - $1.25 Million
29,837 Added 1.43%
2,112,784 $76 Million
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $98,842 - $121,200
-2,870 Reduced 0.14%
2,082,947 $79.6 Million
Q2 2020

Aug 12, 2020

SELL
$30.19 - $39.11 $10.8 Million - $14 Million
-357,917 Reduced 14.65%
2,085,817 $73.2 Million
Q1 2020

May 13, 2020

BUY
$25.83 - $45.71 $5 Million - $8.85 Million
193,524 Added 8.6%
2,443,734 $79.7 Million
Q4 2019

Feb 05, 2020

BUY
$37.87 - $45.37 $11.3 Million - $13.5 Million
297,566 Added 15.24%
2,250,210 $102 Million
Q3 2019

Nov 20, 2019

SELL
$40.31 - $43.45 $16.9 Million - $18.2 Million
-418,027 Reduced 17.63%
1,952,644 $79.5 Million
Q3 2019

Nov 08, 2019

SELL
$40.31 - $43.45 $38,979 - $42,016
-967 Reduced 0.04%
2,370,671 $102 Million
Q2 2019

Aug 26, 2019

SELL
$34.91 - $42.98 $3,386 - $4,169
-97 Reduced -0.0%
2,371,638 $102 Million
Q2 2019

Aug 09, 2019

BUY
$34.91 - $42.98 $6.61 Million - $8.14 Million
189,462 Added 8.68%
2,371,735 $102 Million
Q1 2019

May 03, 2019

BUY
$32.91 - $40.75 $1.77 Million - $2.19 Million
53,798 Added 2.53%
2,182,273 $83.8 Million
Q4 2018

Feb 07, 2019

BUY
$31.73 - $39.04 $1.77 Million - $2.18 Million
55,808 Added 2.69%
2,128,475 $75.2 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $2.61 Million - $3.08 Million
79,623 Added 4.0%
2,072,667 $79.8 Million
Q2 2018

Aug 03, 2018

SELL
$26.84 - $34.32 $55.8 Million - $71.3 Million
-2,078,857 Reduced 51.05%
1,993,044 $65.2 Million
Q1 2018

May 04, 2018

SELL
$25.2 - $28.54 $85.8 Million - $97.1 Million
-3,403,896 Reduced 45.53%
4,071,901 $111 Million
Q4 2017

Feb 01, 2018

BUY
$24.79 - $29.8 $6.85 Million - $8.24 Million
276,390 Added 3.84%
7,475,797 $185 Million
Q3 2017

Nov 02, 2017

BUY
$26.26 - $29.17 $189 Million - $210 Million
7,199,407
7,199,407 $210 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.